The Hyderabad-based Dr Reddy's Labs is planning to launch new generic drugs in various therapeutic segments to give a push to its domestic operations and get back to among the top ten firms in the country.
The firm, which is currently ranked 13th with a 2.7 per cent share in the Rs 55,000-crore domestic pharma market, is working to increase the domestic sales.
"We were among the top 10 domestic pharma companies a few years ago and we expect to be back there," Dr Reddy's Laboratories chief operating officer Satish Reddy said.
The company will launch new products in the domestic market particularly in therapeutic areas like cardiovascular, diabetes and dermatology that have a larger market share, he said without specifying details. He also said the company will be focusing on different region where it doesn't have a strong presence.